IL21 and neoplasm: CAR-T cells with the combined expression of IL-15 and IL-21 showed a less differentiated profile and longer survival in repeated exposures to tumor cells, in addition to maintaining the expression of T-cell factor-1 (TCF-1), an important factor for the development and survival of T cells.